• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗安全科学:惠康信托基金会会议总结。

The science of vaccine safety: Summary of meeting at Wellcome Trust.

机构信息

University of Pennsylvania, Vaxconsult, 4650 Wismer Rd., Doylestown, PA 18902, USA.

The Vaccine Education Center Division of Infectious Diseases, The Children's Hospital of Philadelphia, USA.

出版信息

Vaccine. 2020 Feb 18;38(8):1869-1880. doi: 10.1016/j.vaccine.2020.01.024. Epub 2020 Jan 24.

DOI:10.1016/j.vaccine.2020.01.024
PMID:31987690
Abstract

Vaccines are everywhere hugely successful but are also under attack. The reason for the latter is the perception by some people that vaccines are unsafe. However that may be, vaccine safety, life any other scientific subject, must be constantly studied. It was from this point of view that a meeting was organized at the Wellcome Trust in London in May 2019 to assess some aspects of vaccine safety as subjects for scientific study. The objective of the meeting was to assess what is known beyond reasonable doubt and conversely what areas need additional studies. Although the meeting could not cover all aspects of vaccine safety science, many of the most important issues were addressed by a group of about 30 experts to determine what is already known and what additional studies are merited to assess the safety of the vaccines currently in use. The meeting began with reviews of the current situation in different parts of the world, followed by reviews of specific controversial areas, including the incidence of certain conditions after vaccination and the safety of certain vaccine components. Lastly, information about the human papillomavirus vaccine was considered because its safety has been particularly challenged by vaccine opponents. The following is a summary of the meeting findings. In addition to this summary, the meeting organizers will explore opportunities to perform studies that would enlarge knowledge of vaccine safety.

摘要

疫苗在全球范围内取得了巨大成功,但也受到了攻击。后者的原因是一些人认为疫苗不安全。然而,疫苗安全性与任何其他科学主题一样,必须不断研究。正是出于这个原因,2019 年 5 月在伦敦的惠康信托基金会组织了一次会议,以评估疫苗安全性的某些方面作为科学研究的课题。会议的目的是评估有确凿证据证明的已知内容,以及需要进一步研究的领域。尽管会议无法涵盖疫苗安全科学的所有方面,但由大约 30 名专家组成的小组讨论了许多最重要的问题,以确定已知的内容以及值得进行哪些额外的研究来评估目前使用的疫苗的安全性。会议首先回顾了世界不同地区的现状,然后回顾了特定的争议领域,包括接种疫苗后某些疾病的发病率和某些疫苗成分的安全性。最后,还考虑了人乳头瘤病毒疫苗的信息,因为疫苗反对者对其安全性提出了特别的质疑。以下是会议结果的总结。除了这份总结,会议组织者还将探讨开展研究的机会,以扩大对疫苗安全性的认识。

相似文献

1
The science of vaccine safety: Summary of meeting at Wellcome Trust.疫苗安全科学:惠康信托基金会会议总结。
Vaccine. 2020 Feb 18;38(8):1869-1880. doi: 10.1016/j.vaccine.2020.01.024. Epub 2020 Jan 24.
2
The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.在英国和美国,针对成年人的 COVID-19 疫苗副作用风险的描述和沟通对疫苗接种意愿的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Sep 6;22(1):592. doi: 10.1186/s13063-021-05484-2.
3
Review: Vaccine Myth-Buster - Cleaning Up With Prejudices and Dangerous Misinformation.综述:疫苗迷思终结者——清除偏见和危险的错误信息。
Front Immunol. 2021 Jun 10;12:663280. doi: 10.3389/fimmu.2021.663280. eCollection 2021.
4
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.新冠疫苗的快速研发和早期成功为加速癌症治疗机制带来了希望。
Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1.
5
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.评价由科兴中维生产的新型冠状病毒(灭活)疫苗对医护人员的有效性和安全性的双盲、随机、安慰剂对照 III 期临床试验 - PROFISCOV:一项随机对照试验的研究方案的结构化总结。
Trials. 2020 Oct 15;21(1):853. doi: 10.1186/s13063-020-04775-4.
6
Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity.会议报告:召开通用流感疫苗的流感人类病毒挑战模型会议,第 1 部分:价值;挑战病毒选择;监管、行业和伦理考虑因素;提高标准化、可及性和能力。
Vaccine. 2019 Aug 14;37(35):4823-4829. doi: 10.1016/j.vaccine.2019.06.080.
7
Vaccine safety in the next decade: why we need new modes of trust building.未来十年的疫苗安全:为何我们需要建立信任的新模式。
BMJ Glob Health. 2021 May;6(Suppl 2). doi: 10.1136/bmjgh-2020-003908.
8
Factors that influence caregivers' and adolescents' views and practices regarding human papillomavirus (HPV) vaccination for adolescents: a qualitative evidence synthesis.影响照顾者和青少年对青少年人乳头瘤病毒(HPV)疫苗接种的看法及做法的因素:一项定性证据综合分析
Cochrane Database Syst Rev. 2025 Apr 15;4(4):CD013430. doi: 10.1002/14651858.CD013430.pub2.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).大分子拥挤现象:化学与物理邂逅生物学(瑞士阿斯科纳,2012年6月10日至14日)
Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2.

引用本文的文献

1
Human papillomavirus nonavalent (HPV9) vaccination and risk of immune mediated diseases, myocarditis, pericarditis, and thromboembolic outcomes in Denmark: self-controlled case series study.丹麦人乳头瘤病毒九价(HPV9)疫苗接种与免疫介导疾病、心肌炎、心包炎及血栓栓塞事件风险:自控病例系列研究
BMJ Med. 2024 Oct 22;3(1):e000854. doi: 10.1136/bmjmed-2024-000854. eCollection 2024.
2
Restoring Trust: The Need for Precision Medicine in Infectious Diseases, Public Health and Vaccines.恢复信任:传染病、公共卫生和疫苗领域需要精准医学。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2234787. doi: 10.1080/21645515.2023.2234787. Epub 2023 Jul 19.
3
The Vaccine-Hesitant Moment.
对疫苗犹豫不决的时刻。
N Engl J Med. 2022 Jul 7;387(1):58-65. doi: 10.1056/NEJMra2106441. Epub 2022 Jun 29.
4
Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders.自闭症谱系障碍儿童麻疹和百日咳疫苗的安全性。
Vaccine. 2022 Apr 20;40(18):2568-2573. doi: 10.1016/j.vaccine.2022.03.031. Epub 2022 Mar 18.
5
The Childhood Vaccination Schedule and the Lack of Association With Type 1 Diabetes.儿童疫苗接种时间表与 1 型糖尿病无关。
Pediatrics. 2021 Dec 1;148(6). doi: 10.1542/peds.2021-051910.
6
Quadrivalent human papillomavirus vaccination and non-targeted infectious disease hospitalisation: Population-based self-controlled case series analysis.四价人乳头瘤病毒疫苗接种与非靶向性传染病住院治疗:基于人群的自我对照病例系列分析
Lancet Reg Health Eur. 2021 Aug 28;10:100189. doi: 10.1016/j.lanepe.2021.100189. eCollection 2021 Nov.
7
Prevalence and Determinants of Vaccine Hesitancy and Vaccines Recommendation Discrepancies among General Practitioners in French-Speaking Parts of Belgium.比利时法语区全科医生中疫苗犹豫和疫苗推荐差异的患病率及决定因素
Vaccines (Basel). 2021 Jul 10;9(7):771. doi: 10.3390/vaccines9070771.
8
Review: Vaccine Myth-Buster - Cleaning Up With Prejudices and Dangerous Misinformation.综述:疫苗迷思终结者——清除偏见和危险的错误信息。
Front Immunol. 2021 Jun 10;12:663280. doi: 10.3389/fimmu.2021.663280. eCollection 2021.
9
Vaccine safety in the next decade: why we need new modes of trust building.未来十年的疫苗安全:为何我们需要建立信任的新模式。
BMJ Glob Health. 2021 May;6(Suppl 2). doi: 10.1136/bmjgh-2020-003908.
10
Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.揭示中国民众对新冠病毒疫苗接受度的决定因素。
J Med Internet Res. 2021 Jan 15;23(1):e26089. doi: 10.2196/26089.